Showing 861 - 880 results of 41,701 for search '(( 50 ((a decrease) OR (greater decrease)) ) OR ( a ((point decrease) OR (nn decrease)) ))', query time: 0.92s Refine Results
  1. 861
  2. 862
  3. 863
  4. 864
  5. 865
  6. 866

    Gene clustering identifies up- and down-regulated groups that control development, pluripotency, and cell division. by Michael Shelton (382572)

    Published 2019
    “…<p>Pluripotent H9 hESCs were differentiated for 50 days as previously described [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0222946#pone.0222946.ref012" target="_blank">12</a>], beginning with high (7.5 μM or 10 μM) CHIR99021 concentrations. mRNA samples from the indicated time points were subjected to gene expression profiling. …”
  7. 867
  8. 868
  9. 869
  10. 870
  11. 871
  12. 872
  13. 873
  14. 874

    Inhibition and assessment of the biophysical gating properties of GluA2 and GluA2/A3 AMPA receptors using curcumin derivatives by Mohammad Qneibi (7314050)

    Published 2019
    “…Thus, the current study investigated novel curcumin derivatives on the biophysical properties of AMPA receptors, specifically on the homomeric GluA2 and the heteromeric GluA2/A3 subunits and assessed for inhibitory actions. …”
  15. 875

    Table1_A capillary flow-driven microfluidic device for point-of-care blood plasma separation.DOCX by William Brakewood (14189291)

    Published 2022
    “…The impact of input sample hematocrit percentage on flow rate through the device was also examined, with samples with hematocrits greater than 45% decreasing plasma flow rate. Lastly, we evaluated the ability of this device to produce plasma with a high protein concentration and found no significant difference between protein levels in samples from the device compared to samples produced via centrifugation. …”
  16. 876

    Overexpression of U1 snRNA induces decrease of U1 spliceosome function associated with Alzheimer’s disease by Zhi Cheng (729515)

    Published 2017
    “…These findings not only helped researchers better understand the functions of U1 snRNA, but also paved the way to reveal the mechanisms of AD from a different point of view and may find a new therapeutic target for the disease.…”
  17. 877
  18. 878
  19. 879
  20. 880